Key result
In patients with hepatocellular carcinoma, a blood neutrophil-to-lymphocyte ratio > 3.17 at diagnosis was an independent predictor of tumor size > 5 cm.
Why the study?
The study was conducted to evaluate the relationship between blood neutrophil to lymphocyte ratio and tumor size, tumor number, and macrovascular invasion at diagnosis in hepatocellular carcinoma.
Does an elevated neutrophil to lymphocyte ratio predict tumor size and macrovascular invasion in patients with hepatocellular carcinoma?
Observational (n=48)
No
Does an elevated neutrophil to lymphocyte ratio predict tumor size and macrovascular invasion in patients with hepatocellular carcinoma?
In patients with hepatocellular carcinoma, a neutrophil to lymphocyte ratio > 3.17 at diagnosis is an independent predictor of tumor size > 5 cm and hyponatremia.
Answers are grounded in this paper and cite their sources.
NLR >3.17 may flag larger HCC tumors at diagnosis; hypothesis-generating and requires prospective validation before any clinical role.
Aim: We aimed to show the relationship between blood neutrophil to lymphocyte ratio that is systemic inflammatory marker and tumor size, tumor number, macro-vascular invasion at the time of diagnosis in patients with hepatocellular carcinoma.Methods: A total 48 patients diagnosed with hepatocellular carcinoma were included in our study. The patients were divided into two groups according to the median neutrophil to lymphocyte ratio.Results: A total of 48 patients (11 female, 37 male) were included in our study. The mean age of the patients were 67.18±9.51 years-old. The median neutrophil to lym-phocyte ratio was 3.17. There were significant association between neutrophil to lym-phocyte ratio > 3.17 and macrovascular invasion, the tumor number> 3, the tumor size> 5 cm, Child-Turcot-Pugh score, Model for End-stage Liver Disease- Sodium score, C-reactive protein and blood sodium level (p: 0.005, p: 0.009, p< 0.001, p: 0.003, p:0.008, p: 0.035 and p < 0.001, respectively). Multiple logistic lineer regres-sion analysis showed that NLR> 3.17 was an independent predictor of tumor size> 5 cm and hyponatremia in patients with hepatocellular carcinoma (p: 0.010, p: 0.012, respectively).Conclusions: The value of blood neutrophil to lymphocyte ratio at the time of diag-nosis in patients with hepatocellular carcinoma was a good predictor of tumor size and grade of disease.
No takes yet. Share an insight, caveat, or question.
Özlem Özer Çakır (2019) conducted an observational in Hepatocellular carcinoma (n=48). Neutrophil to lymphocyte ratio (NLR) > 3.17 vs. NLR ≤ 3.17 was evaluated on Tumor size > 5 cm (OR 11.018, 95% CI 1.764-68.831, p=0.010). In patients with hepatocellular carcinoma, a blood neutrophil-to-lymphocyte ratio > 3.17 at diagnosis was an independent predictor of tumor size > 5 cm.
Synapse has enriched 10 related papers. Consider them for comparative context: